Dyne Therapeutics Inc DYN 深滬

等待開盤 01-07 09:30:00 美东时间

18.12

-0.110

-0.60%

華盛通

立即下載

最高18.39
今開18.04
成交量 254.13万股
最低 17.67
昨收 18.23
總市值 29.35亿
52周最高 25.00
市盈率 ^靜 --
換手率 1.57%
52周最低 6.36
委比 -94.59%
總股本 1.62亿
歷史最高 47.45
量比 1.10
振幅 3.95%
歷史最低 4.30
每手 1
風險率 4.07%

個股概要

財務分析

公司資料

分紅派息

分時圖
日k
周k
月k

相關新聞

Dyne Therapeutics Appoints Vikram Karnani to Board of Directors

Dyne Therapeutics announced the appointment of Vikram Karnani to its Board of Directors. Karnani, a seasoned executive in rare disease and biopharmaceuticals, brings extensive experience in product launches and growth. As Dyne prepares for its first potential launch in Q1 2027, Karnani's expertise aligns with the company's goal of advancing treatments for neuromuscular diseases. His appointment is expected to strengthen Dyne's commercial strategy...

2025-12-23 12:30
RenX Enterprises Expands Sustainable Growing Media Initiative Utilizing Ara Partners–Backed Microtec Technology

RenX Enterprises, Inc. has advanced its sustainable growing media initiative using Microtec's advanced milling and materials-engineering technology. This collaboration allows RenX to scale production across multiple facilities, converting local green waste into consistent, high-performance substrates for commercial growers. The products offer an eco-friendly alternative to traditional peat and imported substrates, reducing environmental impact an...

2025-12-22 14:00
Rithm Capital Corp.PA declares $0.6334 dividend

Rithm Capital Corp.PA (RITM.PR.A) declares $0.6334/share quarterly dividend. Forward yield 9.96% Payable Feb. 17; for shareholders of record Jan. 30; ex-div Dec. 30. See RITM.PR.A Dividend Scorecard, ...

2025-12-19 10:10
Rithm Capital declares $0.25 dividend

Rithm Capital (RITM) declares $0.25/share quarterly dividend, in line with previous. Forward yield 8.9% Payable Jan. 30; for shareholders of record Dec. 31; ex-div Dec. 31. See RITM Dividend Scorecard...

2025-12-19 05:37
Lennox Named to the Drucker Institute's Management Top 250

The Drucker Institute recognized Lennox for its strong financial results, customer-focused investments, and continued innovation. DALLAS, Dec. 17, 2025 /PRNewswire/ -- Lennox (NYSE: LII), a ...

2025-12-17 23:00
'Secretary Kennedy Adds Duchenne Muscular Dystrophy, Metachromatic Leukodystrophy To Newborn Screenings' - HHS

https://www.hhs.gov/press-room/secretary-kennedy-adds-duchenne-muscular-dystrophy-metachromatic-leukodystrophy-to-newborn-screenings.html#:~:text=WASHINGTON%E2%80%94DECEMBER%2016%2C%202025%20%E2%80%94,scientific%20review

2025-12-17 00:34
美股大行评级 | 潜在涨幅113%！麦格理首予小马智行“跑赢大市"评级目标价29美元；Roth Capital下调好市多至"卖出"，目标价从906美元降至769美元

今日重点评级关注：HC Wainwright & Co.：维持BioCryst Pharma"买入"评级，目标价从30美元升至32美元；TD Cowen：上调Milestone Pharmaceuticals评级至"买入"，目标价8美元

2025-12-16 09:36
Evercore ISI Group Maintains Outperform on Dyne Therapeutics, Lowers Price Target to $36

Evercore ISI Group analyst Gavin Clark-Gartner maintains Dyne Therapeutics (NASDAQ:DYN) with a Outperform and lowers the price target from $38 to $36.

2025-12-15 22:54
Dynex Capital 6.9% Prfd Series C declares $0.6143 dividend

Dynex Capital 6.9% Prfd Series C (DX.PR.C) declares $0.6143/share quarterly dividend. Forward yield 9.48% Payable Jan. 15; for shareholders of record Jan. 1; ex-div Jan. 1. See DX.PR.C Dividend Scorec...

2025-12-12 21:43
美股大行评级 | 绩后分化！甲骨文遭14家大行集体下调目标价；新思科技、Planet获多家机构上调目标价！

今日重点评级关注：HC Wainwright & Co.：维持Moleculin Biotech"买入"评级，目标价从4美元升至22美元；HC Wainwright & Co.：上调Soluna Holdings评级至"买入"，目标价5美元

2025-12-12 10:24

派息除權日	每股總股息	派息日期
2002-05-30	0.08	2002-06-17
2002-02-27	0.08	2002-03-15
2001-11-29	0.08	2001-12-17
2001-08-29	0.08	2001-09-17
2001-05-29	0.08	2001-06-15
2001-02-27	0.08	2001-03-15
2000-11-29	0.08	2000-12-15
2000-08-29	0.08	2000-09-15
2000-05-26	0.15	2000-06-15
2000-02-24	0.04	2000-03-31
1999-12-01	0.01	1999-12-21
1999-09-01	0.01	1999-09-21
1999-06-01	0.01	1999-06-28
1999-03-04	0.01	1999-03-26
1998-12-01	0.01	1998-12-21
1998-09-01	0.01	1998-09-21
1998-05-28	0.01	1998-06-22
1998-03-09	0.01	1998-03-27
1997-12-01	0.01	1997-12-19
1997-08-22	0.01	1997-09-16
1997-05-21	0.01	1997-06-16
1997-02-13	0.01	1997-03-05
1996-11-27	0.01	1996-12-16
1996-07-25	0.01	1996-09-03
1996-05-16	0.01	1996-06-04
1996-03-21	0.01	1996-04-09
1995-12-14	0.01	1996-01-02
1995-09-21	0.01	1995-10-10
1995-06-16	0.01	1995-07-05
1995-03-01	0.01	1995-03-21
1994-12-01	0.01	1994-12-21
1994-08-31	0.01	1994-09-21
1994-06-01	0.01	1994-06-21
1994-03-01	0.01	1994-03-21
1984-10-03	0.66	1984-11-01
1984-07-03	0.66	1984-08-01
1984-04-04	0.66	1984-05-01
1984-01-04	0.66	1984-02-01
1983-10-03	0.62	1983-11-01
1983-07-05	0.62	1983-08-01
1983-04-05	0.62	1983-05-02
1983-01-04	0.62	1983-02-01
1982-10-04	0.62	1982-11-01
1982-07-02	0.62	1982-08-02
1982-04-02	0.62	1982-05-01
1982-01-05	0.62	1982-02-01
1981-10-05	0.60	1981-11-02
1981-07-06	0.60	1981-08-01
1981-04-06	0.60	1981-05-01
1981-01-05	0.60	1981-02-02
1980-10-06	0.60	1980-11-01
1980-07-03	0.60	1980-08-01
1980-04-02	0.57	1980-05-01
1980-01-03	0.57	1980-01-31
1979-10-02	0.57	1979-10-31
1979-07-02	0.57	1979-07-31
1979-04-03	0.57	1979-04-30
1979-01-03	0.57	1979-01-31
1978-10-02	0.57	1978-10-31
1978-07-02	0.57	1978-07-31
1978-04-03	0.57	1978-04-30
1978-01-03	0.57	1978-01-31
1977-10-02	0.55	1977-10-31
1977-06-30	0.55	1977-07-31
1977-04-03	0.55	1977-05-01

公司名稱	Dyne Therapeutics Inc
行業分類	电力
業務描述	Dyne Therapeutics, Inc. engages in developing innovative life-transforming therapies for genetically driven muscle diseases. It develops a broad portfolio of therapeutics for muscle diseases, including lead programs in myotonic dystrophy type 1, Duchenne muscular dystrophy, and facioscapulohumeral muscular dystroph. The company was founded by Jason P. Rhodes and Romesh R. Subramanian on December 1, 2017 and is headquartered in Waltham, MA.

Dyne Therapeutics Inc DYN 深 滬

18.12

個股概要

財務分析

公司資料

相關新聞

分紅派息

相關新聞

公司簡介

Dyne Therapeutics Inc DYN 深滬